Ładuje się......
Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line
The type I insulin-like growth factor receptor (IGF-1R) signaling pathway is an important growth-regulatory pathway that is prevalent in a variety of cancer types, including human non-small cell lung cancer (NSCLC). To observe the combined effects of gefitinib and AG1024-induced IGF-1R inhibition on...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
D.A. Spandidos
2011
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440787/ https://ncbi.nlm.nih.gov/pubmed/22977626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.324 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|